Time for Rotation<br />By Rev Shark<br />RealMoney.com Contributor<br />4/28/2008 8:16 AM EDT <br /><br /><br />Money is always there, but the pockets change. <br />-- Gertrude Stein<br /><br />The market is at a particularly interesting and important crossroads as we conclude a stellar month for the indices and await the Federal Open Market Committee's decision on interest rates. Conditions are ripe for a rotation of leadership to occur and for new sectors to gain prominence. <br /><br />As we await the Fed decision this week, two themes are developing. First and foremost, there now seems to be a consensus that the market has seen the worst and is ready to start working higher. Even the usually bearish Barron's had a cover story this weekend about how it now time to "stick a toe in" the market as the financial crisis settles down. <br /><br />Certainly the technical conditions of the major indices are looking better. They are all above some key support levels and trending up steadily since the bottom in March. There is some overhead resistance looming, but the short-term trend is certainly positive and there is nothing to indicate that there are major problems at hand. <br /><br />Market sentiment has improved dramatically and there is an almost sanguine attitude that the market has already priced in all our economic woes and is ready to look beyond the debt, housing and recession issues as fiscal and monetary policies start to kick in. Markets are discounting mechanisms that look forward, so it makes sense that they are anticipating better times ahead. The question we have to keep in mind is whether market players are too quick to be optimistic. <br /><br />That brings us to the second theme that is developing, which is increased concerns about inflation, the weak dollar and the big move up in commodity and oil prices. Last week we saw a sharp pullback in commodity-related stocks as hints emerged that the Fed may start to focus more intently on the problem of inflation and the weak dollar. There are strong indications that the Fed may go to a neutral stance after a quarter-point cut on Tuesday. <br /><br />The Wall Street Journal has a strong editorial this morning about how interest rate cuts have done little to ease problems and are in fact causing a whole set of new issues as the dollar weakens. If liquidity problems in the debt market have eased, it isn't because of the aggressive rate cuts. Yet now we have to deal with the consequences of a flood of cheap dollars. <br /><br />We have our work cut out for us this week as we look to navigate a market ripe for rotation. If the Fed starts to focus on fighting inflation and supporting the dollar, the groups that have been leading us lately -- oil, steel, base metals, agriculture and cyclical industry -- are likely to see some selling pressure. The big question is where the money that rotates out of these groups might go. Ideally, we'll see financials, technology and retail benefit, but that is by no means a sure thing. Just this morning, Morgan Stanley is cautious on large-cap banks and recommends selling into rallies. <br /><br />The possible end of rate cuts this week and the added danger of a high level of bullish complacency means the market is ripe for some major volatility. Our job is to be ready to capitalize as new themes start to emerge. The status quo of the past month is going to come to an end very soon. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: SOHU +13.5% (SINA +6.3%, NTES +4.4%, SNDA +4.0% trading higher in sympathy), BEAV +6.1%, EPD +5.0%, BBD +4.2%, CEO +2.9%, VZ +2.1%... M&A news: WWY +25.4% (Wrigley and Mars announce merger agreement for $80 per WWY share in cash)... Select mining/metals stocks showing strength with higher spot prices: LMC +2.9%, GOLD +2.6%, AEM +1.9%, MT +1.6% (plans surcharge for its steel customers - WSJ), AUY +1.6%, AAUK +1.0%... Other news: OSTE +13.3% (Osteotech's Plexur P receives FDA clearance as bone void filler and bone graft extender in spine), IMMR +10.2% (modestly rebounding after last week's 18% drop), F +8.5% (Tracinda announces it intends to make a cash tender offer for up to 20 mln shares stock at a price of $8.50 per share), HSY +5.6% (up in sympathy with WWY), ACGY +4.0% (still checking), AERG +3.9% (receives $4.5 mln U.S. Army contract for laser guided energy program), ABK +3.6% (modestly rebounding from last week's 40%+decline), VMED +2.9% (still checking), CMI +2.9% and DISCA +2.8% (Cramer makes positive comments on MadMoney)... Analyst upgrades: CS +2.6% (upgraded to Peer Perform at Bear Sterns and upgraded to Neutral at tier 1 firm), V +2.4% (initiated with Buy at UBS and initiated with Buy at tier 1 firm and initiated with Buy at SunTrust), NCC +2.2% (upgraded to Outperform from Market Perform at BMO Capital), MRVL +2.1% (upgraded to Outperform at Friedman Billings), MASI +1.8% (upgraded to Buy at Citigroup).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SCMR -14.2%, RDWR -10.7%, SSW -3.7%, SNP -3.5%, LFC -3.4%, SILC -3.2%, IBN -2.5%, PNCL -2.1%, RSH -1.4%... Other news: GMST -20.4% (no specific catalyst; note shareholders vote on MVSN merger tomorrow), MEDX -12.0% (co and BMY announce that the cos will delay the Biologics License Application submission for ipilimumab), CAL -5.1% (rejects merger overtures - WSJ), UBS -2.4% (still checking), LOGI -1.9% (still checking)... Analyst downgrades: UAUA -6.6% (downgraded to Neutral at Credit Suisse), GT -6.6% (downgraded to Neutral at JPMorgan), SHPGY -3.2% (downgraded to Underperform at Credit Suisse), SNCR -2.5% (downgraded to Accumulate at ThinkPanmure), CHE -2.0% (downgraded to Neutral at JPMorgan), AIG -1.6% (downgraded to Neutral at Credit Suisse), POT -1.5% (Hearing removed from Buy List at tier 1 firm), BEBE -1.3% (downgraded to Hold at Brean Murray), ARO -1.2% (downgraded to Neutral at boutique firm), MMR -1.1% (downgraded to Hold at Jefferies), KSS -1.1% (downgraded to Neutral at Baird).